Acera Surgical

medical devices

About

Acera Surgical is a bioscience company based in St. Louis, Missouri, founded in 2013. The company specializes in developing and commercializing synthetic materials for regenerative medicine, particularly in soft-tissue repair. Acera Surgical originated from research led by Dr. Matthew MacEwan at Washington University, focusing on polymer biomaterials and electrospun fiber technology. The company's key innovation is its proprietary electrospun fiber matrix technology, which creates sub-cellular-sized fibers that mimic human tissue. Their products include Cerafix, the first FDA-cleared electrospun dura substitute in the U.S., designed for repairing the dura mater, and Restrata, a fully resorbable fiber matrix for soft-tissue repair and wound management. Acera Surgical aims to enhance patient healing and quality of life through innovative medical devices, targeting healthcare providers in surgical and wound care settings.

Technologies

Route 53 Outlook MailChimp SPF Microsoft Office 365 Google Tag Manager Typekit ASP.NET Microsoft-IIS Google Font API YouTube Mobile Friendly reCAPTCHA Remote

Keywords

biotechnology & medical device healthcare medical equipment manufacturing nanofiber scaffolds biotechnology tissue healing sub-cellular fibers vascularization support clinical case studies chronic wound treatment medical device innovation medical equipment and supplies manufacturing electrospinning process regenerative medicine b2b flexible tissue matrix fibrous matrix design electrospun fiber matrix wound healing support tissue regeneration healthcare technology biocompatibility testing biocompatible fibers fda cleared devices healthcare equipment & supplies synthetic extracellular matrix nanomedical scaffolds biomimetic materials surgical reinforcement synthetic biomaterials

Location

1650 Des Peres Rd, St. Louis, Missouri, United States, 63131-1821

Related Companies

Companies in the same industry